Matches in Nanopublications for { ?s ?p "[We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP-B15, a side effect that can be overcome by U0126 (MEK1/2 inhibitor) or imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1290352.RASQa8sURVT42Ih3bTl7kKtd9AqQd9Hj5ztYxO3HPbhfg130_assertion description "[We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP-B15, a side effect that can be overcome by U0126 (MEK1/2 inhibitor) or imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290352.RASQa8sURVT42Ih3bTl7kKtd9AqQd9Hj5ztYxO3HPbhfg130_provenance.
- NP1290351.RAidM68zrHn6SlOwdN0-I2SI6jD0kYvCWfvFmiRiSNT7c130_assertion description "[We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP-B15, a side effect that can be overcome by U0126 (MEK1/2 inhibitor) or imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290351.RAidM68zrHn6SlOwdN0-I2SI6jD0kYvCWfvFmiRiSNT7c130_provenance.